Infinity Pharmaceuticals
Latest round
- Series B
Last raised
- Jun 2002
Total raised
- $70M
Investors
- 10
About Infinity Pharmaceuticals
Based in Massachusetts, US, and founded in 2001 Infinity Pharmaceuticals, Inc. operates as a developer of medicines for the treatment of cancer. In August 2009, Infinity Pharmaceuticals, Inc. become a publicly listed company on the NASDAQ and has approximately 398 employees. The company's developed products and those under development include therapies targeting hematologic malignancies, or blood cancers; refractory indolent non-Hodgkin lymphoma; refractory chronic lymphocytic leukemia; and solid tumors, including melanoma and non-small cell lung cancer. The company generates revenue by offering the developed therapies to pharmaceutical companies. The company’s future strategy includes further expansion of its clinical development of eganelisib, an experimental drug being investigated as a possible treatment for cancer.
Who invested in Infinity Pharmaceuticals
10 investors across 1 round
See all investors in Infinity Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jun 24, 2002
Amount
$70M
Investors
Questions about Infinity Pharmaceuticals
Who invested in Infinity Pharmaceuticals?
Infinity Pharmaceuticals has 10 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Infinity Pharmaceuticals raised?
Infinity Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Infinity Pharmaceuticals last raise money?
Infinity Pharmaceuticals's most recent round on record is a Series B, in Jun 2002.
What does Infinity Pharmaceuticals do?
Based in Massachusetts, US, and founded in 2001 Infinity Pharmaceuticals, Inc.
Where is Infinity Pharmaceuticals headquartered?
Infinity Pharmaceuticals is headquartered in Cambridge, US.
Which VCs invest in companies like Infinity Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Infinity Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Infinity Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.